Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study was designed to evaluate if, in children with asthma, a stepwise treatment (five
levels varying from once daily fluticasone propionate 100mcg until twice daily a fixed
combination of salmeterol and fluticasone propionate 50/500 mcg) based on symptom scores
alone results in a sub-optimal treatment when compared to treatment based on cumulative
symptom scores and bronchial hyperresponsiveness (PD20 methacholine).